SLXNW
Silexion Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.01
+23.89%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
—
Return on equity
-328.7%
Return on assets
628.4%
Return on invested capital
0.00x
Asset turnover
-$12.4M
Cash from operations
$1.97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026